Drug
Tinzaparin clinical trials
Also written Innohep.
- studies test it
- 36
- open now
- 7
- in phase 3
- 11
- first study started
- 1993
Keep track of what changes. Save the Tinzaparin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
36 studies that test it; most in 2005 (4)
| Year | Studies |
|---|---|
| 1993 | 1 |
| 1994 | 1 |
| 1997 | 1 |
| 2002 | 2 |
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 4 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2013 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 7
- Phase 3
- 11
- Phase 4
- 13
- No phase
- 7
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 34
Ottawa Hospital Research Institute (4) · University of Calgary (3) · LEO Pharma (2) · Assistance Publique - Hôpitaux de Paris (2) · Centre Hospitalier Universitaire, Amiens (1) · University of Melbourne (1) · Galician Research Group on Digestive Tumors (1) · Hospital Universitario Infanta Leonor (1)
Often tested with
Tested in the same studies.
Dalteparin (7) · Enoxaparin (6) · Rivaroxaban (2) · Apixaban (2) · Nafamostat (1) · Nirmatrelvir (1) · Ritonavir (1) · Remdesivir (1)
Studies
Open first, then newest update. How each study uses Tinzaparin is read from its arms, and is right about nine times in ten.
Testing it · 36
- Thromboprophylaxis in Lower Limb ImmobilisationRecruitingPhase 3Queen Mary University of LondonNCT06370273Written as Tinzaparin Injectable Solution
- THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)RecruitingPhase 4Imperial College LondonNCT05735639Written as Tinzaparin Sodium
- The OAT Trail: The Obesity Anti-Coagulation Thromboprophylaxis Trial.Not yet recruitingNot applicableUniversity College DublinNCT07559643Written as Tinzaparin (Leo)
- Tinzaparin And Biomarkers After Neoadjuvant Treatment of Ovarian CancerRecruitingPhase 2University Hospital, LinkoepingNCT05284552Written as Tinzaparin Injectable Solution
- LDA and LMWH vs LDA Alone in High-risk Patients for Preeclampsia PreventionRecruitingPhase 4Alexandra Hospital, Athens, GreeceNCT07361679Written as Tinzaparin
- STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated ThrombosisRecruitingPhase 4Tzu-Fei WangNCT05255003Written as Tinzaparin
- Pre- Vs. Postoperative Thromboprophylaxis in Pancreatic SurgeryRecruitingPhase 4Helsinki University Central HospitalNCT05245877Written as enoxaparin/tinzaparin/dalteparin
- TINzaparin Prophylaxis in Patients With Metastatic Colorectal CancerCompletedPhase 3Galician Research Group on Digestive TumorsNCT05625932Written as Tinzaparin
- Effect of Tinzaparin on Inflammatory Biomarkers During the Acute Phase of Deep Vein ThrombosisActive, not recruitingNot applicableCentre Hospitalier Universitaire, AmiensNCT04741464Written as Tinzaparin
- Innohep® in Elderly Patients With Impaired Renal Function Treated for Acute Deep Vein ThrombosisCompletedPhase 4LEO PharmaNCT00277394Written as innohep®
- Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in CancerCompletedPhase 3LEO PharmaNCT01130025Written as Innohep®
- Australasian COVID-19 Trial (ASCOT) ADAptive Platform TrialActive, not recruitingPhase 3University of MelbourneNCT04483960Written as (Arm Closed) Tinzaparin
- Tinzaparin Lead-In to Prevent the Post-Thrombotic SyndromeTerminatedPhase 4Sunnybrook Health Sciences CentreNCT04794569Written as tinzaparin
- Therapeutic Anticoagulation Strategy for Acute Chest SyndromeCompletedPhase 3Assistance Publique - Hôpitaux de ParisNCT02580773Written as Prophylactic anticoagulation ( INNOHEP®)
- Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer (PROVE)TerminatedPhase 3Assistance Publique - Hôpitaux de ParisNCT03090880Written as Tinzaparin Sodium
- Standard vs High Prophylactic Doses or Anticoagulation in Patients With High Risk of Thrombosis Admitted With COVID-19 Pneumonia (PROTHROMCOVID)CompletedNot applicableHospital Universitario Infanta LeonorNCT04730856Written as Tinzaparin
- Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in PregnancyCompletedPhase 4Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)NCT01828697Written as Fixed low dose tinzaparin
- The Impact of Thromboprophylaxis on Progression Free Survival of Patients With Advanced Pancreatic CancerStatus unknownPhase 3Michalis KaramouzisNCT05178628Written as Innohep
- Extended Peri-operative Tinzaparin to Improve Disease-free Survival in Patients With Resectable Colorectal CancerCompletedPhase 3Ottawa Hospital Research InstituteNCT01455831Written as Tinzaparin
- The STOP CLOT Pilot Study: Study of Low Molecular Weight Heparin in High Risk Cesarean SectionCompletedPhase 2/3Ottawa Hospital Research InstituteNCT00225108Written as Tinzaparin
See all 36 studies that test Tinzaparin →
Given in every arm · 2 — Tinzaparin is usual care beside what is tested
- A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous ThromboembolismStatus unknownPhase 3The University of Hong KongNCT03240120Written as Tinzaparin
- Tinzaparin in the Treatment of the Acute Pulmonary EmbolismCompletedPhase 4Complejo Hospitalario Xeral-CaldeNCT00711308Written as tinzaparin
Codes
What other systems call Tinzaparin · ClinicalTrials.gg INT006820
- MeSH (NLM) D000078222TinzaparinConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 7UQ7X4Y489TINZAPARINConfirmed FDA, NLM, Wikidata
- RxNorm 69646Confirmed FDA, Wikidata
- Wikidata Q20817252tinzaparinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C87297TinzaparinOne source FDA
- DrugBank DB06822One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000078222 | Tinzaparin | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 7UQ7X4Y489 | TINZAPARIN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 69646 | — | Confirmed FDA, Wikidata |
| Wikidata | Q20817252 | tinzaparin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C87297 | Tinzaparin | One source FDA |
| DrugBank | DB06822 | — | One source Wikidata |
Also registered as tinzaparin sodium (UNII 3S182ET3UA · RxNorm 104466).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.